These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 35799937)

  • 21. The regulatory role of invariant NKT cells in tumor immunity.
    McEwen-Smith RM; Salio M; Cerundolo V
    Cancer Immunol Res; 2015 May; 3(5):425-35. PubMed ID: 25941354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing NKT cell ligands as vaccine adjuvants.
    Carreño LJ; Kharkwal SS; Porcelli SA
    Immunotherapy; 2014; 6(3):309-20. PubMed ID: 24762075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A divergent approach to the synthesis of iGb3 sugar and lipid analogues via a lactosyl 2-azido-sphingosine intermediate.
    Cheng JM; Dangerfield EM; Timmer MS; Stocker BL
    Org Biomol Chem; 2014 May; 12(17):2729-36. PubMed ID: 24652424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells.
    Porubsky S; Speak AO; Salio M; Jennemann R; Bonrouhi M; Zafarulla R; Singh Y; Dyson J; Luckow B; Lehuen A; Malle E; Müthing J; Platt FM; Cerundolo V; Gröne HJ
    J Immunol; 2012 Sep; 189(6):3007-17. PubMed ID: 22875802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Species-specific activity of glycolipid ligands for invariant NKT cells.
    Dangerfield EM; Cheng JM; Knight DA; Weinkove R; Dunbar PR; Hermans IF; Timmer MS; Stocker BL
    Chembiochem; 2012 Jun; 13(9):1349-56. PubMed ID: 22639457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutting edge: structural basis for the recognition of β-linked glycolipid antigens by invariant NKT cells.
    Yu ED; Girardi E; Wang J; Zajonc DM
    J Immunol; 2011 Sep; 187(5):2079-83. PubMed ID: 21810611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors.
    Pellicci DG; Clarke AJ; Patel O; Mallevaey T; Beddoe T; Le Nours J; Uldrich AP; McCluskey J; Besra GS; Porcelli SA; Gapin L; Godfrey DI; Rossjohn J
    Nat Immunol; 2011 Jul; 12(9):827-33. PubMed ID: 21804559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced antitumor effects by chemical modified IGb3 analogues.
    Zhou Z; Zhang C; Xia C; Chen W; Zhu H; Shang P; Ma F; Wang PG; Zhang J; Xu W; Tian Z
    Mol Cancer Ther; 2011 Aug; 10(8):1375-84. PubMed ID: 21653685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells.
    Wun KS; Cameron G; Patel O; Pang SS; Pellicci DG; Sullivan LC; Keshipeddy S; Young MH; Uldrich AP; Thakur MS; Richardson SK; Howell AR; Illarionov PA; Brooks AG; Besra GS; McCluskey J; Gapin L; Porcelli SA; Godfrey DI; Rossjohn J
    Immunity; 2011 Mar; 34(3):327-39. PubMed ID: 21376639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SnCl(4)- and TiCl(4)-catalyzed anomerization of acylated O- and S-glycosides: analysis of factors that lead to higher α:β anomer ratios and reaction rates.
    Pilgrim W; Murphy PV
    J Org Chem; 2010 Oct; 75(20):6747-55. PubMed ID: 20836488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzymatic synthesis of Gb3 and iGb3 ceramides.
    Adlercreutz D; Weadge JT; Petersen BO; Duus JØ; Dovichi NJ; Palcic MM
    Carbohydr Res; 2010 Jul; 345(10):1384-8. PubMed ID: 20206917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands.
    Florence WC; Xia C; Gordy LE; Chen W; Zhang Y; Scott-Browne J; Kinjo Y; Yu KO; Keshipeddy S; Pellicci DG; Patel O; Kjer-Nielsen L; McCluskey J; Godfrey DI; Rossjohn J; Richardson SK; Porcelli SA; Howell AR; Hayakawa K; Gapin L; Zajonc DM; Wang PG; Joyce S
    EMBO J; 2009 Nov; 28(22):3579-90. PubMed ID: 19816402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation.
    Im JS; Arora P; Bricard G; Molano A; Venkataswamy MM; Baine I; Jerud ES; Goldberg MF; Baena A; Yu KO; Ndonye RM; Howell AR; Yuan W; Cresswell P; Chang YT; Illarionov PA; Besra GS; Porcelli SA
    Immunity; 2009 Jun; 30(6):888-98. PubMed ID: 19538930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunologic glycosphingolipidomics and NKT cell development in mouse thymus.
    Li Y; Thapa P; Hawke D; Kondo Y; Furukawa K; Furukawa K; Hsu FF; Adlercreutz D; Weadge J; Palcic MM; Wang PG; Levery SB; Zhou D
    J Proteome Res; 2009 Jun; 8(6):2740-51. PubMed ID: 19284783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha anomers of iGb3 and Gb3 stimulate cytokine production by natural killer T cells.
    Yin N; Long X; Goff RD; Zhou D; Cantu C; Mattner J; Mezard PS; Teyton L; Bendelac A; Savage PB
    ACS Chem Biol; 2009 Mar; 4(3):199-208. PubMed ID: 19175331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation.
    Christiansen D; Milland J; Mouhtouris E; Vaughan H; Pellicci DG; McConville MJ; Godfrey DI; Sandrin MS
    PLoS Biol; 2008 Jul; 6(7):e172. PubMed ID: 18630988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and structure-activity relationship study of isoglobotrihexosylceramide analogues.
    Chen W; Xia C; Wang J; Thapa P; Li Y; Talukdar A; Nadas J; Zhang W; Zhou D; Wang PG
    J Org Chem; 2007 Dec; 72(26):9914-23. PubMed ID: 18020363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of the ceramide moiety of isoglobotrihexosylceramide on its agonist activity in stimulation of invariant natural killer T cells.
    Xia C; Schümann J; Emmanuel R; Zhang Y; Chen W; Zhang W; De Libero G; Wang PG
    J Med Chem; 2007 Jul; 50(15):3489-96. PubMed ID: 17608465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation.
    McCarthy C; Shepherd D; Fleire S; Stronge VS; Koch M; Illarionov PA; Bossi G; Salio M; Denkberg G; Reddington F; Tarlton A; Reddy BG; Schmidt RR; Reiter Y; Griffiths GM; van der Merwe PA; Besra GS; Jones EY; Batista FD; Cerundolo V
    J Exp Med; 2007 May; 204(5):1131-44. PubMed ID: 17485514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals.
    Speak AO; Salio M; Neville DC; Fontaine J; Priestman DA; Platt N; Heare T; Butters TD; Dwek RA; Trottein F; Exley MA; Cerundolo V; Platt FM
    Proc Natl Acad Sci U S A; 2007 Apr; 104(14):5971-6. PubMed ID: 17372214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.